Introduction
Irritable bowel syndrome (IBS) is the most common functional gastrointestinal disorder of the developed world (Chang, Reference Chang2004). Its prevalence in the general population is estimated to lie between 10% and 22% (Jones and Lydeard, Reference Jones and Lydeard1992; Kennedy et al., Reference Kennedy, Jones, Hungin, O’Flanagan and Kelly1998; Hungin et al., Reference Hungin, Whorwell, Tack and Mearin2003; Wilson et al., Reference Wilson, Roberts, Roalfe, Bridge and Sukhdev2004). Although it is likely to be closer to 10%, as studies reporting higher figures are biased through selectively assessing gastrointestinal symptoms, this still translates into annual NHS care costs of £45.6 million (Inadomi et al., Reference Inadomi, Fennerty and Bjorkman2003). The condition gives rise to a substantial workload in both primary and secondary care, with one-third to one-half of IBS patients consulting a general practitioner (GP) at least once (Jones and Lydeard, Reference Jones and Lydeard1992; Wilson et al., Reference Wilson, Roberts, Roalfe, Bridge and Sukhdev2004), and around 30% of these being referred to a specialist (Thompson et al., Reference Thompson, Heaton, Smyth and Smyth2000).
IBS is a chronic, relapsing and often lifelong disorder whose long-term morbidities cause insomnia, anxiety and lethargy (NICE, 2007), leading to time off work (Akehurst et al., Reference Akehurst, Brazier, Mathers, O’Keefe, Kaltenthaler, Morgan, Platts and Walters2002), avoidance of stressful or social situations and an associated and repeatedly documented reduction in the quality of life (QOL; Akehurst et al., Reference Akehurst, Brazier, Mathers, O’Keefe, Kaltenthaler, Morgan, Platts and Walters2002; El-Serag et al., Reference El-Serag, Olden and Bjorkman2002; Chang, Reference Chang2004; Halder et al., Reference Halder, Locke, Talley, Fett, Zinsmeister and Melton2004; Pare et al., Reference Pare, Gray, Lam, Balshaw, Khorasheh, Barbeau, Kelly and McBurney2006). The EQ-5D scale, a validated measure of health-related QOL (Akehurst et al., Reference Akehurst, Brazier, Mathers, O’Keefe, Kaltenthaler, Morgan, Platts and Walters2002; Pare et al., Reference Pare, Gray, Lam, Balshaw, Khorasheh, Barbeau, Kelly and McBurney2006), has been used in several studies to estimate the QOL of a particular patient group. Collectively, these studies show that IBS patients have a QOL similar to that seen in patients with lower back pain (Brazier et al., Reference Brazier, Roberts, Tsuchiya and Busschbach2004; Lamers et al., Reference Lamers, Meerding, Severens and Brouwer2005; Pare et al., Reference Pare, Gray, Lam, Balshaw, Khorasheh, Barbeau, Kelly and McBurney2006) and ankylosing spondylitis (Kobelt et al., Reference Kobelt, Andlin-Sobocki and Maksymowych2006), and worse than that seen in patients with gastro-oesophageal reflux disease (Kartmen et al., Reference Kartmen, Gatz and Johannesson2004). It has even been suggested that the impact on the QOL experienced by patients with IBS may be similar to that experienced in congestive heart failure (Whitehead et al., Reference Whitehead, Burnett, Cook and Taub1996).
The pathophysiology of IBS remains poorly understood and there is an absence of effective treatment options (Horwitz and Fisher, Reference Horwitz and Fisher2001; Talley and Spiller, Reference Talley and Spiller2002). This, together with the significant demand IBS places on health service resources (Pare et al., Reference Pare, Gray, Lam, Balshaw, Khorasheh, Barbeau, Kelly and McBurney2006), is a source of frustration for doctors who are unable to provide clear evidence and advice to their patients and have to form their own experienced-based views and management approaches towards IBS (Dixon-Woods and Critchley, Reference Dixon-Woods and Critchley2000).
Dixon-Woods and Critchley (Reference Dixon-Woods and Critchley2000) showed that GPs tend to hold both ‘public’ and ‘private’ views regarding IBS. Public views are based on a textbook definition, usually including a list of symptom criteria, while private views tend to be based on the application of a psychosocial model and the labelling of IBS patients as ‘the worried well’ (Dixon-Woods and Critchley, Reference Dixon-Woods and Critchley2000). Where doctors hold these private views, the doctor–IBS patient relationship may be compromised, and patients may report being left feeling that their symptoms have been trivialised (Dixon-Woods and Critchley, Reference Dixon-Woods and Critchley2000; Bertram et al., Reference Bertram, Kurland, Lydick, Locke and Yawn2001). IBS patients who have a poor relationship with their doctor have been shown to have low compliance with treatment, to consult multiple practitioners and to force through unnecessary, invasive and expensive clinical tests (Meadows et al., Reference Meadows, Lackner and Belic1997; Dixon-Woods and Critchley, Reference Dixon-Woods and Critchley2000). Other patients stop consulting, resulting in their self-medicating or suffering in silence in the community (Jones and Lydeard, Reference Jones and Lydeard1992; Dixon-Woods and Critchley, Reference Dixon-Woods and Critchley2000; Bertram et al., Reference Bertram, Kurland, Lydick, Locke and Yawn2001). Little is known of the coping strategies of those who do not seek medical attention (Hahn et al., Reference Hahn, Saunders and Maier1997; Akehurst et al., Reference Akehurst, Brazier, Mathers, O’Keefe, Kaltenthaler, Morgan, Platts and Walters2002).
A review of the literature from the last 15 years (using PubMed) indicated that although quantitative data have repeatedly demonstrated that IBS reduces the QOL (Akehurst et al., Reference Akehurst, Brazier, Mathers, O’Keefe, Kaltenthaler, Morgan, Platts and Walters2002; El-Serag et al., Reference El-Serag, Olden and Bjorkman2002; Chang, Reference Chang2004; Halder et al., Reference Halder, Locke, Talley, Fett, Zinsmeister and Melton2004; Pare et al., Reference Pare, Gray, Lam, Balshaw, Khorasheh, Barbeau, Kelly and McBurney2006), there is little robust qualitative research exploring the range of mechanisms through which QOL is affected. Questionnaire studies that have attempted to evaluate the impacts of IBS are highly structured and preclude any patient experiences that were not anticipated by the researchers (Pare et al., Reference Pare, Gray, Lam, Balshaw, Khorasheh, Barbeau, Kelly and McBurney2006; Lacy et al., Reference Lacy, Weiser, Noddin, Robertson, Crowell, Parratt-Engstrom and Grau2007). One less structured study that aimed to explore the IBS patient perspective used a postal questionnaire with a single open question (Bengtsson et al., Reference Bengtsson, Ohlsson and Ulander2007). Without the use of full interviews, such methodology produces qualitative data that are lacking in depth and have not allowed the researcher to clarify or probe for the true meaning. Another study, aiming to explore the impacts of IBS, sampled just seven female students, some of whom had a diagnosis of inflammatory bowel disease (Schneider and Fletcher, Reference Schneider and Fletcher2008).
Other qualitative studies have been too focused in their approach, exploring patients’ beliefs about either the cause of their disease, the doctor–patient relationship or the effects of dietary changes on symptoms (Meadows et al., Reference Meadows, Lackner and Belic1997; Dixon-Woods and Critchley, Reference Dixon-Woods and Critchley2000; Fletcher and Schneider, Reference Fletcher and Schneider2006; Jamieson et al., Reference Jamieson, Fletcher and Schneider2007). Such studies fail to explore the impact of IBS on daily life in a broad context. However, one recent qualitative study, which aimed to understand patients’ explanatory models for IBS, gave a clearer picture of the impact that IBS has on daily living. The study found that IBS had significant dampening effects on daily life and that patients went to great lengths to prevent the condition from doing so (Casiday et al., Reference Casiday, Hungin, Cornford, de Wit and Blell2009). Moreover, both this study and a recent focus group study revealed that patients did not discuss with their doctors the full extent to which their IBS affected them, leaving doctors relatively uninformed of the impacts of this condition (Casiday et al., Reference Casiday, Hungin, Cornford, de Wit and Blell2009; Drossman et al., Reference Drossman, Chang, Schneck, Blackman, Norton and Norton2009). However, no previous paper has fully explored the complex psychosocial consequences or challenges to personal identity and role, which arise from disease impact on daily living and adaptation. There has, furthermore, been a tendency to use a medical framework in design and analysis in previous studies, which has perhaps limited their ability to comment fully on the personal impacts of illness.
Therefore, this study, through the use of in-depth interviews, aims to build on what is known about the daily impacts of IBS, and highlight the long-term effects of IBS on patients and the psychosocial consequences of the illness. The study focuses on individuals who have suffered with IBS for many years as it is this group of patients that represents the greatest challenge to the primary healthcare system. We have consciously avoided using a medical framework in analysis to ensure that patient experience can be fully portrayed. Enhanced understanding of the impacts of the condition will facilitate future patient management and may help to raise the profile of IBS on the research agenda.
Methods
A qualitative approach using semi-structured interviews was adopted. Participants were recruited from IBS research databases of community-based patients. Sampling patients who had already partaken in IBS research offered several advantages. It ensured that the IBS status of the patients had been confirmed, that demographic and symptom data were available on each participant, enabling purposive sampling, and that a high positive response rate could be expected.
Participants from two recent studies were eligible to be interviewed. The first study, an IBS prevalence study (Wilson et al., Reference Wilson, Roberts, Roalfe, Bridge and Sukhdev2004), had subsequent follow-up data that enabled identification of ‘chronic IBS sufferers’ who matched Rome II diagnostic criteria in both 2002 and 2006. The second was a functional food trial that aimed to determine the value of consumption of probiotic yoghurts in IBS (currently in analysis). Inclusion criteria for this trial were a clinical diagnosis of IBS (confirmed by a specialist or GP) or the satisfaction of the ROME III criteria when assessed by questionnaire. Both samples were recruited through primary care databases and are therefore believed to represent the condition spectrum diagnosed and managed in this setting.
Fifteen individuals were initially contacted from the prevalence study with a further 20 invited from the functional food trial once the initial data collection was complete. All 35 IBS research participants had given permission for their contact details to be retained. Individuals were selected purposively, to include a range of ages, genders and symptom profiles (IBS-subtype (Tillisch et al., Reference Tillisch, Labus, Naliboff, Bolus, Shetzline, Mayer and Chang2005) and severity (Francis et al., Reference Francis, Morris and Whorwell1997)), with the aim of capturing a wide variety of patient experiences (Todres, Reference Todres2005).
A letter of invitation, a patient information sheet detailing the purpose of the study, a telephone number in case of query, a reply form and a freepost envelope were sent to these patients, of whom 20 agreed to participate. Two of these were not immediately contactable, and were not pursued further as data saturation had been achieved. Patients were contacted by telephone and an interview arranged in their homes at their convenience. Interviews were conducted by either author; both were female, a non-clinical researcher and a medical student, respectively. Ethics approval for the study was granted by Wolverhampton Local Research Ethics Committee (LREC) and Nottingham LREC.
Before the interview, each participant gave written consent for the interview to be audiotaped, having been assured of confidentiality by the researcher. Interviews lasted around 40 min, ranging from 20 to 70 min. They were based on a semi-structured topic guide (see Appendix, Figure 1) that aimed to explore the IBS patient experience through discussion about the impact of their IBS on everyday life, fears, beliefs and coping strategies. All issues raised by the participants were expanded upon to ensure that patient experience was fully captured. Data were collected and analysed iteratively, which allowed the interviewer to follow participant responses and enabled a gradual focusing on emergent themes from one interview to the next. The concurrent collection and analysis of the interviews also allowed for further sampling to identify confirmatory or deviant cases and served as a validity check (Murphy et al., Reference Murphy, Dingwall and Greatbatch1998).
All interviews were transcribed in full and imported into NVivo software for thematic analysis. One researcher (RF) systematically reviewed the tapes and transcripts to identify key and recurrent words and themes and applied initial coding to the data. A second researcher (LR) reviewed the initial coding and discussion among the two researchers was used to consolidate ideas and confirm the accuracy of the emerging themes. Further recoding, consisting of the constant comparison of coding units and categories in order to develop higher order categories or ‘main themes’, resulted in the construction of a best-fit thematic framework for the data (Ritchie et al., Reference Ritchie, Spencer and O’Connor2003). The goal was to describe the complete range of patient experiences rather than to expect a convergence or consensus of the data set. Themes arising from final interviews fitted codes that had already been described and established and no new codes were developing. We were therefore confident that data saturation had been achieved.
In tandem with the formal data collected at each interview, an observation diary was kept by the interviewer who recorded reflections on the interviews and notes on analytical thoughts and decisions as they occurred. This ensured transparency between the researchers.
Results
Eighteen participants were interviewed and their characteristics are summarised in Figure 2 (see Appendix). The IBS–QOL (Patrick et al., Reference Patrick, Drossman, Frederick, Dicesare and Puder1998) scores of the chronic sufferers (range 44–111) and the IBS symptom severity scores of the functional food trial participants (range 77–440) indicate a reasonable QOL, but with a wide variation between participants. Five main themes emerged from the interviews: symptom experience and the impact of IBS on daily living, emotional well-being, health service use and identity. All themes emerged spontaneously from the data and were present in both men and women. A thematic framework for the impacts of IBS is shown in Figure 4 (see Appendix). Quotes from the raw data are displayed in Figures 3, 5, 6, 7 and 8 (see Appendix) and themes supported by them are indicated by figure number and quote reference throughout the results section.
Symptom experience
Abdominal pain was the most commonly experienced symptom and was frequently cited as the worst aspect of the condition to cope with (3a, 3b). Mothers described the pain as worse than labour pain (3c). The pain had numerous consequences – it caused a loss of concentration, a lack of sleep, fainting, vomiting, the inability to move or lift and therefore work, a low libido and depression. Constipation, which could last for weeks at a time (3d), was associated with the worst of the pains and resulted in bloating, which was a cause of physical discomfort and embarrassment (3e). Diarrhoea was less painful but often extremely urgent (3f, 3g). Symptoms were unpredictable and participants remained uncertain about specific triggers and warning signs (3h). Participants also described IBS as having an impact on their general health with many suffering exhaustion, temperatures, nausea and depression (3i, 3j).
Impact on daily living
Participants described how IBS caused them to adopt either adaptive changes or avoidance strategies, both of which had significant impacts on their daily living. Adaptive changes allowed participants to maintain a fairly normal level of functioning, whereas avoidance tended to reduce this ability. However, at times, adaptation and avoidance were inadequate coping mechanisms and IBS became disruptive. Impacts on daily living were surprisingly consistent across sub-types of IBS; for example, social activities were sometimes compromised by the need to be near private toilets, but this applied both to those with diarrhoea (urgency) and constipation (to prevent embarrassment from flatulence).
Adaptive strategies were in part patient created but for many incorporated the advice or medication provided by their doctor (5a, 5b). Pragmatic solutions were often adopted, such as carefully planning routes to include toilets, waking up earlier to allow bowel function to normalise before leaving the house, carrying spare underwear, air freshener and painkillers and planning the day around times when the worst symptoms were anticipated (5c). When conventional medication was inadequate to control the symptoms, participants sought out alternatives in the shape of alternative therapies and dietary modifications (5d).
Psychological coping techniques were also apparent. These included maintaining hope, seeking comfort in family and friends, maintaining a sense of humour and making a conscious effort to relax. Humour was particularly effective as it enabled participants to share their knowledge and fears with other people (5e). Almost all participants stated that keeping impacts to a minimum was a case of ‘mind over matter’, suggesting the importance of support from both family and healthcare practitioners (5f).
Many participants indicated that they had their own technique for inducing bowel movement, which was used either to prepare for a normal day or as a reaction to an extreme or unpredictable situation. Such techniques ranged from caffeine, nicotine and exercise through to abdominal massage but also included physically removing the stool with a gloved hand (5g, 5h). Strategies used by participants to manage symptoms were an integral part of daily living, and changes or events that threatened these routine coping strategies caused stress, which would further exacerbate symptoms.
Avoidance strategies occurred when symptoms presented, or when there was a fear that the symptoms would present, at a particularly inconvenient or embarrassing time. Avoidance could occur alongside adaptation. Participants reported avoiding certain clothes, public toilets, restaurants, holidays, new situations where toilet facilities were unknown and even at times leaving the house (5i–5k).
In spite of the use of both adaptive and avoidance strategies, participants described four aspects of life that were significantly disrupted by IBS. These were basic functioning (walking, working and sleeping), relationships, self-image and psychological well-being (5l–5p). Excessive bloating caused participants to worry about their appearance (5l). Partnerships were strained due to participants suffering low moods, low self-esteem and consequent low libido and through finding sex physically uncomfortable (5m, 5n). All of these, together with the lack of available treatment, led to despair and depression in some individuals (5p).
Emotional impact
Participants described a range of negative emotions attributed to their IBS. These included depression, fear, anxiety and embarrassment (6a, 6b). Depression occurred when participants had suffered for a protracted period and had been unsuccessful with treatment (6c). Many participants described that fearing IBS was a misdiagnosis and that something more sinister had been missed (6d). This fear was strengthened by extreme symptoms, a family history of bowel cancer or something similar and a lack of faith in the health service (6e–6g). Situational fears, in which the participant feared their symptoms presenting at an inconvenient time, were also common. Many participants reported emotional cycles in which fear led to stress and consequent exacerbation of symptoms, which acted to further increase the fear (6h). Participants felt that it was therefore important for doctors to understand their fears in order for progress to be made with their treatment (6g).
Impact on health service use
Most participants reported an alienation from the health services and three principal reasons emerged as to why this was the case (Figure 4). The first was a poor doctor–patient relationship. Participants described doctors who undervalued symptoms, contradicted each other, failed to build a relationship with them and who gave limited or no explanation about how to manage IBS (7a–7c). The second was the belief that the NHS could offer no help for IBS based on past experience or on the experiences of others (7d, 7e) Third, participants attributed the onset or worsening of their symptoms to previous medical care (7f, 7g). In contrast, participants who were happy with their treatment described doctors who had fully investigated their fears and whose support had helped put their minds at rest (6g).
Impact on identity
Many participants reported integration of the disease into their lives so completely that it had become a part of their sense of identity. Participants explained that because of the length of their suffering or because they coped through normalising their symptoms, they were sometimes unaware of the everyday adjustments they made (8a–8d). In some cases, this normalisation was doctor reinforced (8e). However, there were also individuals who believed their IBS threatened aspects of their identity, such as their role as a mother, partner or friend (8f–8h).
Discussion
In accordance with what is already known about the patient experience of IBS (Dixon-Woods and Critchley, Reference Dixon-Woods and Critchley2000; Bertram et al., Reference Bertram, Kurland, Lydick, Locke and Yawn2001; Lacy et al., Reference Lacy, Weiser, Noddin, Robertson, Crowell, Parratt-Engstrom and Grau2007; Drossman et al., Reference Drossman, Chang, Schneck, Blackman, Norton and Norton2009), the majority of participants in this study reported their IBS symptoms to be painful and unpredictable and therefore having a significant impact on their QOL. Many previous quantitative studies have shown that IBS results in a reduced QOL, (Akehurst et al., Reference Akehurst, Brazier, Mathers, O’Keefe, Kaltenthaler, Morgan, Platts and Walters2002; El-Serag et al., Reference El-Serag, Olden and Bjorkman2002; Chang, Reference Chang2004; Halder et al., Reference Halder, Locke, Talley, Fett, Zinsmeister and Melton2004; Pare et al., 2006), and this study gives an insight into the mechanisms through which QOL is affected. It confirms recent findings of the extensive impact of IBS on daily living (Casiday et al., Reference Casiday, Hungin, Cornford, de Wit and Blell2009), but has also exposed the additional impacts of IBS on emotional well-being and self-identity, which arise either because of the impact on daily living or adaptation and avoidance strategies.
IBS impacted on daily living through the adoption of coping strategies used by participants to manage their symptoms, reconfirming recent findings by Casiday et al. (Reference Casiday, Hungin, Cornford, de Wit and Blell2009) that patients make great efforts not to allow the condition to take over their lives. Coping strategies were in part patient created but for many incorporated advice or medication provided by their doctor. This is in contrast to previous research, which found that patients are left frustrated by the ineffective advice they receive from doctors and therefore tend to be non-compliant with it (Dixon-Woods and Critchley, Reference Dixon-Woods and Critchley2000). These findings highlight the importance of doctors in helping patients with IBS achieve optimal symptom management. Coping strategies were an integral part of daily living and changes or events, which threatened their completion caused stress, which further exacerbated symptoms. It has long been established that IBS is associated with anxiety and depression (Herschbach et al., Reference Herschbach, Henrich and Von Rad1999; Nicholl et al., Reference Nicholl, Halder, Macfarlane, Thompson, O’Brien, Musleh and McBeth2007; Pare et al., 2007), and participants explained that this occurred when coping strategies were inadequate or they remained fearful of the emergence of unpredictable symptoms. This fear explains the recent findings by Drossman et al. (Reference Drossman, Chang, Schneck, Blackman, Norton and Norton2009) that IBS can restrict activities even when symptoms are not actively present. Previous studies have indicated that IBS is an example of somatisation, whereby anxiety and/or depression can cause IBS (Locke et al., Reference Locke, Weaver, Melton and Talley2004; Nicholl et al., Reference Nicholl, Halder, Macfarlane, Thompson, O’Brien, Musleh and McBeth2007). However, our findings indicate that patients feel the opposite to also be the case, namely that IBS can trigger depression and anxiety.
In accordance with previous studies (Dixon-Woods and Critchley, Reference Dixon-Woods and Critchley2000; Lacy et al, Reference Lacy, Weiser, Noddin, Robertson, Crowell, Parratt-Engstrom and Grau2007; Casiday et al., Reference Casiday, Hungin, Cornford, de Wit and Blell2009), the fear that IBS was a misdiagnosis and that something more sinister (usually bowel cancer) had been missed was apparent in many of the participants in this study. Several participants attributed this fear to perpetuating a vicious cycle in which their fear caused them stress, causing their symptoms to worsen, which acted to strengthen their initial fear. Vicious cycles have been described in previous IBS research (Dixon-Woods and Critchley, Reference Dixon-Woods and Critchley2000) and the data from this study add that for many patients it is the underlying fear of misdiagnosis that triggers the cycle. This finding reinforces the importance of doctors who understand the concerns of this patient group in enabling their optimal management.
In accordance with previous qualitative research on IBS (Meadows et al., Reference Meadows, Lackner and Belic1997; Dixon-Woods and Critchley, Reference Dixon-Woods and Critchley2000; Bertram et al., Reference Bertram, Kurland, Lydick, Locke and Yawn2001; Lacy et al., Reference Lacy, Weiser, Noddin, Robertson, Crowell, Parratt-Engstrom and Grau2007), the present findings also highlight patients’ feelings of being let down by the health services, and go further to explore the reasons why this is the case. Participants complained of a poor relationship with their GP, a lack of information from their GP and medical advice that had worsened their condition. For example, the standard advice to increase dietary fibre had exacerbated symptoms in some participants, a finding supported by previous research (Casiday et al., Reference Casiday, Hungin, Cornford, de Wit and Blell2009). This provides some explanation as to why it is that almost half of the people with IBS do not consult a doctor (Jones and Lydeard, Reference Jones and Lydeard1992; Wilson et al., Reference Wilson, Roberts, Roalfe, Bridge and Sukhdev2004). Furthermore, this study provides a clearer understanding of the complex coping strategies adopted by these non-consulters in the community, data that had previously been lacking (Hahn et al., Reference Hahn, Saunders and Maier1997; Akehurst et al., Reference Akehurst, Brazier, Mathers, O’Keefe, Kaltenthaler, Morgan, Platts and Walters2002).
In contrast to the previously reported ‘worried well’ label (Dixon-Woods and Critchley, Reference Dixon-Woods and Critchley2000), many participants reported integration of the condition into their lives to the extent that it became a part of their sense of identity. However, other participants, or at times the same participant recalling a different situation, felt that because IBS prevented their involvement in everyday roles and activities, it became a threat to their identity. This mirrors the observation made by Dixon-Woods and Critchley (Reference Dixon-Woods and Critchley2000) that doctors distinguish between ‘good’ and ‘bad’ IBS patients. ‘Good’ patients accept their diagnosis while ‘bad’ patients resent their IBS label, reflecting the integration or confrontation observed in patients in this study. In contrast to the doctors’ fixed views, patients felt that this classification was flexible in that they could have both ‘good’ and ‘bad’ days.
Our findings suggest that the reduced QOL highlighted in previous studies (Akehurst et al., Reference Akehurst, Brazier, Mathers, O’Keefe, Kaltenthaler, Morgan, Platts and Walters2002; El-Serag et al., Reference El-Serag, Olden and Bjorkman2002; Chang, Reference Chang2004; Halder et al., Reference Halder, Locke, Talley, Fett, Zinsmeister and Melton2004; Pare et al., 2007) is an underestimate of the overall impact of IBS since patients integrate IBS into their lives to the extent that it becomes a part of their sense of identity. This study therefore reconfirms the finding of Casiday et al. (Reference Casiday, Hungin, Cornford, de Wit and Blell2009) that patients are likely to underreport the extent to which IBS affects their lives. However, Casiday et al. (Reference Casiday, Hungin, Cornford, de Wit and Blell2009) reported that this was because patients adopted a stoical approach to coping with their IBS. This is in contrast to our own data that suggest that this is less to do with the patient’s stoicism and more to do with patients allowing the condition to become a part of their sense of identity. Moreover, the replication of this result is in itself important and further suggests that IBS has a much wider impact than previously reported.
Strengths and limitations
This study was strengthened by the use of in-depth interviews and by its exploration of the patient perspective. Purposive sampling enabled the exploration of the impact of IBS on individuals not only with differing demographic profiles but also with different symptom profiles and severity scores. This sets it apart from many previous qualitative IBS studies which have chosen to focus exclusively on women (Dixon-Woods and Critchley, Reference Dixon-Woods and Critchley2000; Bengtsson et al., Reference Bengtsson, Ohlsson and Ulander2007; Jamieson et al., Reference Jamieson, Fletcher and Schneider2007; Schneider and Fletcher, Reference Schneider and Fletcher2008). Although reliability may have been compromised by the use of a single coder for initial coding, the impact of this will have been minimised by the use of a second researcher to review the raw data and input to the developing coding framework.
Recruitment for both previous studies was through primary care, and therefore the sample in this study is broadly representative of those that consult here. However, it must be acknowledged that those with worse symptoms are always more likely to participate in research, and therefore the experiences described in this study are likely to reflect those of individuals with more severe IBS or IBS that impacts on life more significantly. While the sample was limited to those who had partaken in previous IBS research, and therefore may not be generalisable to all people with IBS, this recruitment method allowed the study to focus on people who were long-term sufferers of IBS. The study therefore gives an important insight into the impact IBS has on chronic sufferers; a group of patients whom the primary healthcare system has struggled to accommodate so far.
Implications for future research or clinical practice
Previous research has reported a need for medical professionals to have a greater insight into the impact of IBS on patients’ lives (Dixon-Woods and Critchley, Reference Dixon-Woods and Critchley2000; Bertram et al., Reference Bertram, Kurland, Lydick, Locke and Yawn2001; Bengtsson et al., Reference Bengtsson, Ohlsson and Ulander2007). This study reconfirms recent findings of the extensive impact of IBS on daily living (Casiday et al., Reference Casiday, Hungin, Cornford, de Wit and Blell2009), but has also exposed the additional impacts of IBS on emotional well-being and personal identity. These findings provide doctors with a greater understanding of the impacts of this condition with which they can aim to foster better relations with this patient group. In particular, this study has highlighted that patient fears are likely to compromise the successful management of IBS and doctors should therefore explore patient fears from the outset.
Future research should investigate factors associated with the adoption of maladaptive (avoidance or disruptive) coping strategies, what can be done to prevent this, and whether or not the coping strategies identified by this study can be generalised to other psychosomatic diseases.
Acknowledgements
Thanks are due to Ms Deborah McCahon for her correspondence with the ethics committees and to the interview participants themselves for their time and enthusiasm. This study was funded in part by the Midlands Research Consortium (MidReC) and in part via the University of Birmingham Medical School BMedSc student research budget. Ethics approval was granted by Wolverhampton LREC reference number 05/Q2701/87, and Nottingham LREC reference number 07/Q2404172.
Competing interests: none declared.
Appendix
Figure 1 Interview topic guide
Figure 1 (Continued)
Figure 2 Participant characteristics
Figure 3 Symptom experience.
Figure 4 Thematic framework displaying the Impacts of irritable bowel syndrome (IBS)
Figure 5 Impact on daily living
Figure 5 (Continued)
Figure 6 Emotional impact
Figure 7 Impact on health service use
Figure 8 Impact on identity
